ArticleBMC medicine2023

Downregulation of AC092894.1 promotes oxaliplatin resistance in colorectal cancer via the USP3/AR/RASGRP3 axis.

Zhijian Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.